New Report
2018-06-08
Forbes China interviewed Zensun’s CEO Dr. Mingdong Zhou and reviewed the history that Mr. Zhou discovered the ‘first in class’ anti-heart failure drug rhNRG-1.
For original paper, please click http://www.forbeschina.com/review/201206/0017257.shtml
更多动态
Dr. Barry h. Greenberg (international authority in heart failure, professor at UCSD) analyzed the prospects for the widespread use of Zensun’s new drug in his publication
“Nature Reviews Drug Discovery,” the world's top pharmaceutical journal, published a paper citing the research results of Zensun's new drug